DOI:
10.1055/s-00032260
Digestive Disease Interventions
LinksClose Window
References
Sherman SK, Lange JJ, Dahdaleh FS. et al.
Cost-effectiveness of maintenance capecitabine and bevacizumab for metastatic colorectal cancer.
JAMA Oncol 2019;
5 (02) 236-242
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.